Moderna (MRNA) announced this week that it has made all required submissions to the Food & Drug Administration for emergency use authorization of its COVID-19 vaccine in adolescents and children.
This, along with today’s broader market rally, has our MRNA May Week Two (5/13) 120 Put trading well out of the money. Let’s watch it expire worthless and I will recommend a new put to sell soon to reduce our net debit on the position.
If you are an Income Masters member, note that we continue to track the ongoing net debit we have in MRNA in that program as well.
Current Stock Price: $140.08
Net Debit: $6.32
Action: Watch put expire worthless